Ā | Control eGFRā>ā60 | DKDĀ eGFRā>ā60 A1ā+āA2 | DKDĀ eGFRā<ā60 A3 |
---|---|---|---|
n (F/M) | 8 (4/4) | 10 (7/3) | 25 (7/18) |
Age (years) | 68.5 (58ā84) | 68 (53ā75) | 69 (55ā87) |
eGFR (mL/min/1.73m2) | 84.5 (63ā102) | 82.0 (61ā131) | 25 (10ā46)# |
AER (mg/g creatinine) | ā | 9.5 (2.4ā114) | 1128 (317ā6430)@ |
Time of DM (years) | ā | 14 (4ā26) | 18 (6ā30) |
CVD history (%) | ā | 2 (20%) | 11 (44%) |
BMI (kg/m2) | 24.9 (21ā29) | 33 (25ā45) * | 27 (21ā38) |
HbA1c (%) | 5.6 (5.0ā6.0) | 8.4 (7.0ā8.0)# | 8.3 (6.0ā10.0) # |
Fructosamine (Ī¼mol/L) | 219 (205ā262) | 308 (158ā428)& | 331 (329ā506) & |
TC (mg/dL) | 208 (155ā290) | 144 (114ā186)$ | 154 (92ā313) |
TG (mg/dL) | 111 (71ā362) | 88 (64ā151) | 148 (78ā329) |
HDLc (mg/dL) | 49 (33ā87) | 46 (35ā92) | 40 (21ā140) |
CML (Ī¼g/mL) | 0.5 (0.3ā1.0) | 1.7 (0.5ā3.4) | 1.0 (0.7ā7.3) |